COLD SPRING HARBOR, N.Y., Nov. 4, 2010 /PRNewswire/ — AccuVein
LLC, the developer of the first non-contact, handheld vein
illumination system, announced today that it had been awarded the
maximum grant amount from the Qualifying Therapeutic Discover
Project (QTDP) program. This Federal grant program supports
projects that show significant potential to produce new therapies,
address unmet medical needs, and reduce the long-term growth of
health care costs.
AccuVein’s AV300 helps health care professionals locate veins
for blood draw, IV infusion and blood donation by projecting a
pattern of light on patient’s skin that reveals the position of
underlying veins. This 10-ounce, hand-held device is
available with a range of hands-free options so that it can quickly
free the practitioner’s hands to perform the venipuncture. It
is the first and only system of its kind.
“Hospitals are adopting vein visualization as the
standard-of-care for venipuncture as a tool to reduce error, reduce
cost and increase patient satisfaction,” said AccuVein engineering
vice president Joe Zott. “Winning this grant will support our
continued investment in delivering the best vein illumination
system in the market.”
About AccuVein
AccuVein LLC is a supplier of innovative, cutting-edge medical
devices. The award winning AV300 allows health care providers to
see a map of the position of peripheral veins on the skin’s surface
with the goal of helping to improve venipuncture procedures. Built
using AccuVein’s expertise in medical device miniaturization and
user-intuitive design, the AV300 is the world’s first portable,
non-contact vein illumination solution. The AccuVein AV300 was the
recipient of the 2010 Medical Design Excellence Award and was cited
as a 2009 best new product in Contemporary Pediatrics Magazine.
AccuVein has filed applications for more than a dozen
patents on the AV300’s technology. It is in use at more than 400
U.S. h
‘/>”/>
